Skip to main content

Table 2 Differences in periodontal parameters between baseline and 6-month follow-up visit (Me [IQR])

From: Influence of adjunctive azithromycin on microbiological and clinical outcomes in periodontitis patients: 6-month results of randomized controlled clinical trial

 

Control group

Test group

p

All probing sites

 PlI (%)

29.0 (15.2–32.6)

22.6 (14.8–34.1)

0.589

 GBI (%)

7.6 (0.0–26.2)

3.7 (1.9–10.2)

0.529

 PD (mm)

1.1 (0.8–1.6)

1.4 (1.1–1.5)

0.358

 REC (mm)

− 0.2 (− 0.6 – − 0.1)

− 0.3 (− 0.4 – − 0.1)

0.672

 CAL (mm)

0.7 (0.5–1.2)

1.0 (0.7–1.3)

0.287

 BOP (%)

51.2 (36.0–64.4)

49.4 (31.1–66.7)

0.930

Sites with initial PD < 5 mm

 PlI (%)

20.2 (15.1–30.9)

16.1 (9.8–31.0)

0.726

 GBI (%)

8.3 (0.0–22.5)

3.3 (0.6–9.1)

0.547

 PD (mm)

0.5 (0.3–0.7)

0.7 (0.5–0.8)

0.068

 REC (mm)

− 0.2 (− 0.5 – − 0.1)

−0.2 (− 0.3–0.0)

0.511

 CAL (mm)

0.3 (− 0.1–0.6)

0.5 (0.2–0.7)

0.140

 BOP (%)

46.9 (37.6–63.7)

47.1 (29.7–65.3)

0.884

Initially deep probing sites (PD ≥ 5 mm) without BOP

 PlI (%)

4.5 (0.0–31.8)

27.3 (0.0–35.4)

0.753

 GBI (%)

0.0 (0.0–0.0)

0.0 (− 3.3–0.0)

0.601

 PD (mm)

2.0 (2.0–2.6)

2.6 (2.2–2.9)

0.110

 REC (mm)

−0.6 (− 0.9–0.0)

−0.3 (− 0.5–0.0)

0.274

 CAL (mm)

1.9 (1.0–2.3)

2.3 (2.0–2.5)

0.151

 BOP (%)

/

/

/

Initially diseased probing sites (PD ≥ 5 mm and BOP)

 PlI (%)

31.0 (23.4–47.0)

33.3 (22.2–46.9)

0.804

 GBI (%)

7.9 (0.0–30.8)

1.6 (0.0–14.8)

0.486

 PD (mm)

2.6 (2.2–2.9)

2.5 (2.3–3.1)

0.849

 REC (mm)

−0.4 (− 0.6–0.2)

−0.5 (− 0.6 – − 0.3)

0.693

 CAL (mm)

2.1 (1.6–2.4)

2.2 (1.5–2.7)

0.942

 BOP (%)

/

/

/

  1. Me median value, IQR interquartile range, PlI plaque index; GBI gingival bleeding index; PD probing depth; REC recession; CAL clinical attachment loss; BOP bleeding on probing